Europe needs gene patent lawsBMJ 1996; 312 doi: https://doi.org/10.1136/bmj.312.7035.868a (Published 06 April 1996) Cite this as: BMJ 1996;312:868
- Alexander Dorozynski
Inadequate patent laws may impede Europe's ability to exploit the mapping and sequencing of the human genome for medical and pharmaceutical purposes, a leading expert on patent law has warned. Professor Joseph Straus, chairman of the intellectual property rights committee of the Human Genome Organisation, was speaking …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial